Document and Entity Information
Document and Entity Information | Jan. 18, 2022 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jan. 18, 2022 |
Entity Registrant Name | Brooklyn ImmunoTherapeutics, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-11460 |
Entity Tax Identification Number | 31-1103425 |
Entity Address, Address Line One | 140 58th Street, Building A |
Entity Address, Address Line Two | Suite 2100 |
Entity Address, City or Town | Brooklyn |
Entity Address, State or Province | NY |
Entity Address, Postal Zip Code | 11220 |
City Area Code | 212 |
Local Phone Number | 582-1199 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0000748592 |
Title of 12(b) Security | Common Stock, par value $0.005 per share |
Trading Symbol | BTX |
Security Exchange Name | NASDAQ |